Patent Assignment
Reel/Frame 022718/0843
Assignment of Assignor's Interest
Recorded: 2009-05-21
Pages: 2
Assignee
LEAD THERAPEUTICS, INC.
999 BAYHILL DRIVE, SUITE 130, SAN BRUNO, CALIFORNIA, 94066
Covered Property
(1)
Dihydropyridophthalazinone Inhibitors of Poly(Adp-Ribose)Polymerase (Parp)
Application:
61/173,088 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 3, 2011
From: LEAD THERAPEUTICS, INC.
To: BIOMARIN PHARMACEUTICAL INC.
Reel/Frame 025765/0990 →
Security Interest
Oct 23, 2015
From: MEDIVATION, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036866/0635 →
Assignment of Assignor's Interest
Mar 30, 2016
From: BIOMARIN PHARMACEUTICAL INC.
To: MEDIVATION, INC.
Reel/Frame 038137/0906 →
Assignment of Assignor's Interest
Mar 30, 2016
From: MEDIVATION, INC.
To: MEDIVATION TECHNOLOGIES, INC.
Reel/Frame 038138/0043 →
Release of Security Interest
Sep 28, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: MEDIVATION, INC.
Reel/Frame 039873/0219 →
Certificates of Formation and Conversion
Oct 19, 2018
From: MEDIVATION TECHNOLOGIES, INC.
To: MEDIVATION TECHNOLOGIES LLC
Reel/Frame 047273/0892 →